TrademarkDir
AURINIA
LIVE

Serial Number

87604403

Owner

AURINIA PHARMACEUTICALS INC.

Attorney

Matthew R. Wilmot

Filing Date

Sep 12, 2017

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

AURINIA Trademark

Serial Number: 87604403 • Registration: 6430762

AURINIA is a trademark filed by AURINIA PHARMACEUTICALS INC. on September 12, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

AURINIA PHARMACEUTICALS INC. (34 trademarks)

1203-4464 Markham St.

Entity Type: 11

Trademark Details

Filing Date

September 12, 2017

Registration Date

July 27, 2021

Published for Opposition

May 11, 2021

Goods & Services

(Based on 44(e)) Pharmaceutical preparations for the treatment of autoimmune disorders, kidney disorders, opthamalogical disorders and lupus nephritis

(Based on 44(e)) (Based on Use in Commerce) Research and development of medicinals and pharmaceuticals

Filing History

REGISTERED-PRINCIPAL REGISTER
Jul 27, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 11, 2021 NPUB
PUBLISHED FOR OPPOSITION
May 11, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 21, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 6, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 6, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 6, 2021 CRFA
ASSIGNED TO LIE
Apr 1, 2021 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 30, 2021 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Dec 4, 2020 GNS2
INQUIRY TO SUSPENSION E-MAILED
Dec 4, 2020 GNSI
SUSPENSION INQUIRY WRITTEN
Dec 4, 2020 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 12, 2020 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 6, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
May 6, 2020 GNSL
SUSPENSION LETTER WRITTEN
May 6, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 14, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 13, 2020 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 13, 2020 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Oct 21, 2019 GNS2
INQUIRY TO SUSPENSION E-MAILED
Oct 21, 2019 GNSI
SUSPENSION INQUIRY WRITTEN
Oct 21, 2019 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Sep 27, 2019 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 25, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 25, 2019 GNSL
SUSPENSION LETTER WRITTEN
Feb 25, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 1, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 1, 2019 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 30, 2019 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Aug 4, 2018 GNS2
INQUIRY TO SUSPENSION E-MAILED
Aug 4, 2018 GNSI
SUSPENSION INQUIRY WRITTEN
Aug 4, 2018 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jul 16, 2018 RCCK
ASSIGNED TO LIE
Jul 13, 2018 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 16, 2017 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 16, 2017 GNSL
SUSPENSION LETTER WRITTEN
Dec 16, 2017 CNSL
ASSIGNED TO EXAMINER
Dec 15, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 16, 2017 NWOS
NEW APPLICATION ENTERED
Sep 15, 2017 NWAP

Related Trademarks

More from this Owner

LUPUS NEPHRITIS PEER CONNECT

LUPUS NEPHRITIS PEER CONNECT

LUPUS NEPHRITIS PEER CONNECT

LUPUS NEPHRITIS PEER CONNECT

LOSING MORE THAN TIME

LOSING MORE THAN TIME

LOSING MORE THAN TIME

LOSING MORE THAN TIME

LOSING MORE THAN TIME

LOSING MORE THAN TIME

ENLIGHT-LN

ENLIGHT-LN